The United States Food and Drug Administration (FDA) is introducing the Digital Health Center of Excellence within the Center for Devices and Radiological Health (CDRH), it was reported on Tuesday.
The US FDA is to continue to build and formalise the coordinating structure and operation of the Digital Health Center of Excellence under its effort to modernise digital health policies and regulatory approaches.
The FDA is naming Bakul Patel as the first director. He has been leading regulatory and scientific efforts related to digital health devices at the US FDA since 2010.
Spinogenix to present SPG601 Phase 2a trial results at AACAP Conference
AnnJi Pharmaceutical secures FDA Fast Track Designation for AJ201 in rare neuromuscular disease
Myosin Therapeutics' MT-125 granted US FDA Fast Track designation in glioblastoma
Boehringer Ingelheim's JASCAYD (nerandomilast) IPF treatment gains Chinese regulatory approval
Galera Therapeutics sells dismutase mimetics portfolio to Biossil in USD108.5m agreement
Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis
Sanofi's efdoralprin alfa shows superior results in phase 2 study for AATD
FDA accepts Xspray Pharma's NDA for XS003 with PDUFA date set for June 2026
Citius Oncology and McKesson sign US distribution agreement for LYMPHIR
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio